The concentration of leptin that generated an increase in the expression of both receptors of adiponectin was that corresponding to normal weight (10 ng/mL), indicating that in said condition, adiponectin can successfully carry out its antiproliferative activity over cancer cells and, in this manner, generate a form of protection for the patient. This evidence concerns the gene ADIPOQ and cancer.